The effects of acute administration of tumour necrosis factor-a (cachectin) (TNF-a) or of malignant tumour growth (Walker-256 carcinosarcoma) on hepatic availability and uptake of individual amino acids were compared. The results show that, in spite of lowering the hepatic availability of alanine, aspartate, serine, glycine and proline, the cytokine increased both the total amino acid hepatic uptake and the individual uptakes of alanine, glutamate, serine, threonine, proline, lysine and arginine, while decreasing those of leucine, isoleucine and phenylalanine. Tumour burden resulted in an increase in the hepatic availability of glutamine, threonine, glycine, lysine, leucine, isoleucine, valine and phenylalanine. Total liver amino acid uptake was unaffected, whereas the individual uptakes of alanine, threonine and proline were increased and those of glutamate, glutamine, serine and leucine were decreased. When effects of the cytokine are compared with those induced by tumour growth, there are similar increases in net utilization for alanine, proline and leucine, and a 3-fold difference in the increase observed for threonine. Unmatched effects are seen for glutamate, glutamine, aspartate, glycine, lysine, arginine, valine, phenylalanine and serine.
INTRODUCTION
The metabolic response to a number of invasive stimuli involves the secretion of cytokines by a variety of cells such as macrophages and lymphocytes Dinarello, 1988) . Among these compounds, tumour necrosis factor-a (TNF-a; cachectin) has been shown to inhibit the synthesis of lipoprotein lipase in transformed mouse fibroblast and adipocyte (3T3-LI) cells (Price et al., 1986; Kawakami et al., 1987) and also to stimulate lipolysis in these cells. It has also been shown that TNF-a is able to decrease lipid absorption and tissue uptake and oxidation in vivo, with resultant hypertriglyceridaemia (Evans & Williamson, 1988b) . This cytokine also stimulates amino acid release (Mahony et al., 1988) and uptake from muscle (Argiles et al., 1989) , increased uptake of amino acids by the liver (Roh et al., 1986; Warren et al., 1987 Warren et al., , 1988 Argiles et al., 1989) , and increased hepatic synthesis of acute-phase-reaction proteins (Darlington et al., 1986; Perlmutter et al., 1986) . These metabolic alterations are associated not only with infectious diseases but also with malignant tumour growth, which is characterized by muscle and adipose tissue wasting, which leads to weight loss and anorexia through accelerated muscle proteolysis and adiposetissue lipolysis, enhanced rates of hepatic fatty acid oxidation and gluconeogenesis from lactate, amino acids and glycerol (Shapot, 1979; Lawson et al., 1982; Argiles & Azcon-Bieto, 1988) . Several studies have attributed TNF-ac a central role in cancer-induced cachexia (Oliff et al., 1987; Stovroff et al., 1988; Tracey et al., 1988) . Indeed, recent work has shown that TNF-ac has acute effects on exogenous lipid metabolism (Evans & Williamson, 1988b; Argiles et al., 1989) which in part mimic those of rapidly growing tumours in the pre-anorexic phase (Evans & Williamson, 1988a 
Cytokine administration
The animals were injected with 20,g of human recombinant-derived TNF-a in 0.5 ml of Krebs-Henseleit (1932) (Herzfeld & Greengard, 1972) . The amount implanted ensured that the tumour mass was 2-5 % ofcarcass weight at the time ofthe experiments (7-10 days after implantation).
Experimental design
The different experimental groups, control (salineinjected), TNF-injected and tumour-bearing, were each randomly divided into two different subgroups for two different sets of experiments. In the first, the portal and hepatic blood flows were measured. In the second, the arteriovenous amino acid concentration differences across the liver were estimated.
Blood-flow determinations
The portal and hepatic blood flows were estimated by a modification of the indicator-dilution method (Katz & Bergman, 1969; Casado et al., 1987) This was carried out in deproteinized blood samples from the portal and hepatic veins and aorta with an automatic amino acid analyser (Lee & Drescher, 1978 Blood flows
The total hepatic blood flows were 3.5 + 0.3, 3.0 + 0.3 and 3.6 + 0.7 ml/min per g of liver for control, TNFtreated and tumour-bearing groups respectively. Although there were no statistical differences between these values, the portal blood flow was significantly lower (P < 0.05) in the TNF-treated group than that of the control group. The portal blood flows were 1.9 + 0.2, 1.3 + 0.1 and 2.0 + 0.4 ml/min per g of liver for control, TNF-treated and tumour-bearing groups respectively. TNF administration inhibits gastric emptying in the rat (Tracey et al., 1988) , and this fact may possibly be related to a lower portal blood flow.
Amino acid concentrations
These are presented as nmol/ml in Table 1 , which shows that administration of the cytokine decreased the arterial blood concentrations of alanine (25 %), serine (32 %), glycine (24 %) and proline (41 %). Tumour burden resulted in a lower arterial concentration of glutamate (36 %) and proline (34 %), whereas it increased those of glutamine (23 %) glycine (24 %), leucine (37 %) and phenylalanine (29 %) . No significant changes in total amino acid concentration were found between the different groups studied. Others have reported that there were no significant changes in plasma amino acids in 24 h-starved tumour-bearing rats compared with nonVol. 266 tumour-bearing controls when decreased food intake was not manifest (Arbeit et al., 1985) . These results fully agree with those reported with a similar experimental design (Argiles et al., 1989) .
TNF-a administration resulted in a significant increase in the portal concentrations of glutamine and lysine, but it decreased the venous concentrations of alanine, glutamate, serine, threonine, proline and isoleucine. On the other hand, tumour-bearing animals showed decreased portal concentrations of glutamate, aspartate and proline, but increased concentrations of threonine, lysine, leucine, isoleucine and phenylalanine. In the same experimental group there were significant decreases in the venous concentrations of alanine, threonine, proline and valine and increases in those of glutamine, glycine and leucine. Amino acid availabilities TNF treatment induced a decreased hepatic availability (,umol of amino acid reaching the liver/min per 100 g body wt.) for alanine (29 %O), serine (25 %O), glycine (28 %) and proline (48 %o), but it did not affect the total amino acid availability (Table 2 ). In contrast, tumour growth increased the availabilities for threonine (43 %O), glycine (65 %), isoleucine (65 %o), valine (41 %o) and phenylalanine (63 %). No significant changes were observed in total amino acid availability in the tumourbearing animals. Net hepatic utilization TNF treatment resulted in an increased utilization of alanine, glutamate, serine, threonine, proline, lysine, and arginine, but decreased that of leucine, isoleucine and phenylalanine. Tumour-bearing animals showed an increased utilization of alanine, threonine and proline and a diminished utilization of glutamate, glutamine, serine and leucine.
Concluding remarks
The present results show that TNF administration to rats can mimic some of the effects of malignant tumour growth on hepatic amino acid utilization. This is especially the case for the amino acids that can be transported through the A system, some of them clearly gluconeogenic precursors: alanine, threonine, proline and other neutral ones. These results are in full agreement with the uptake results reported by us using a-aminoisobutyrate, a non-metabolizable analogue of alanine (Argiles et al., 1989) .
The enhanced hepatic utilization of gluconeogenic amino acids is indeed a well-known phenomenon in tumour-bearing animals (Shapot, 1979; Lawson et al., 1982; Argiles & Azcon-Bieto, 1988) and has been related to the action of glucocorticoids on liver amino acid transport, the concentration of these hormones being specially high in the host (Saez, 1971) . On the other hand, TNF administration also modifies the corticosteroid status of the animal (Argiles et al., 1989) 
